News & Articles
Selected Filters:
Avacta receives clinical validation of AffiDX SARS-CoV-2 antigen lateral flow test
The test offers 98.0% clinical sensitivity for samples with PCR Ct values up to 31
Take your pick of 8 expert webinars this week
Reserve your place today for talks on topics ranging from food fraud, spatial infiltration and CRISPR to antibody and AAV gene therapies
Euroimmun launches SARS-CoV-2 NeutraLISA Assay to determine the neutralizing capacity of antibodies
CE marked assay based on well-established ELISA technology expands Euroimmun's offerings for labs that seek to understand immune response to COVID-19
Roche launches Elecsys Epstein-Barr Virus (EBV) immunoassay panel to improve EBV infection staging
The EBV panel can be used to rule out other acute infections, such as missed HIV infections
Beckman Coulter Life Sciences brightens flow cytometry with new SuperNova polymer dyes portfolio
Next-generation polymer dyes can improve accuracy and brightness with reduced nonspecific staining
IONTAS identifies novel SARS-CoV-2 neutralizing antibodies
Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant
Twist Bioscience and Kyowa Kirin partner for GPCR antibody discovery
Twist Biopharma will leverage its biologics and proprietary discovery capabilities to find novel GPCR target-specific antibodies for Kyowa Kirin
Investigating traditional and modern approaches to antimicrobial susceptibility testing
In this on-demand webinar, we look at ways to improve time to result in critical pathways such as sepsis
Aptamer Group and Mologic partner to develop aptamer-based SARS-CoV-2 rapid antigen test
This partnership aims to offer an accelerated route to market rapid test technologies
Beckman Coulter's SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from FDA
Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test
USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
Beckman Coulter offers $4/high-throughput antigen test to support U.S. government initiative to expand COVID-19 testing
The company is set to support the $12 billion expansion in COVID-19 testing as vaccinations increase
Scientists rate the latest technologies in the field of engineered antibodies
Take a look at what other researchers and scientists are saying about cutting-edge technologies in engineered antibodies
10 top new resources to advance your engineered antibody research
Explore our exclusive interviews, free downloads, latest methods, and much more to help support your antibody research
Vote for the Best New Life Sciences Product in the 2021 Scientists’ Choice Awards
For a chance to win a $500/£400/450€ Amazon Gift Card, cast your vote for the new product which has made the most difference to your research
AstraZeneca provides an update on the safety of the COVID-19 vaccine
The monthly safety report will be made public on the European Medicines Agency website
Transform your immunoassay: Choose the right antibody for you
Dr. Christian Frisch explains how to design a reliable assay and reveals how Bio-Rad and Sartorius teamed up to help scientists achieve peak immunoassay performance
Watch highlights from the Virtual Analytical Summit 2021
Top talks presenting the latest technologies, research and applications are now available on demand
























